Joseph Samsa

• Represents LabCorp Oncology portfolio which includes: NGS panels – Solid Tumor & Hematology, Pathology, Hematopathology, and Clinical testing.
• Call points include Medical Oncology, Hematology, Pathology, Urology, Hospital and Clinical Labs.
• 2025 YTD Oct.

99% to goal, 13% YOY growth

• 2024

110% to goal, 14% YOY growth

• 2023

92% to goal, 4% YOY growth

• Represented Toxicology and Pharmacogenetic testing to large scope of specialties that included: Pain Management, Psychiatry, Addiction Medicine, Internal Medicine, and Family Practice.
• Trained account managers on testing and managed campaigns to grow toxicology testing in accounts.

• Identified new business opportunities through cold calling, networking, marketing and prospective database leads.
• Collaborated with other departments to address customer needs and service requests.